Biogen Idec Inc. - Financial and Strategic Analysis ReviewSummaryBiogen Idec Inc. (Biogen) is a biotechnology company, involved in the development, manufacturing and commercialization of novel therapies used in the areas of oncology, neurology, immunology and cardiology. The company operates in more than 90 countries worldwide and principally operates in Canada, Australia, Japan and Europe. The company is headquartered in Massachusetts, U.S. and employs 4,300 people approximately. The company recorded revenue of $3,062.9 million during the fiscal year ended December 2007, an increase of 18.2% over 2006. The operating profit of the company was $684.79 million during the fiscal year 2007, an increase of 116.1% over 2006.Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Biogen Idec Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.Scope-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. -The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. -The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy-A quick 'one-stop-shop' to understand the company. -Enhance business/sales activities by understanding customers' businesses better.-Get detailed information and financial & strategic analysis on companies operating in your industry.-Identify prospective partners and suppliers ' with key data on their businesses and locations.-Capitalize on competitors' weaknesses and target the market opportunities available to them.-Compare your company's financial trends with those of your peers / competitors.-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Biogen Idec Inc. - Financial and Strategic Analysis Review
Published on April 2009
Report Summary
Biogen Idec Inc. - Financial and Strategic Analysis Review
Summary
Biogen Idec Inc. (Biogen) is a biotechnology company, involved in the development, manufacturing and commercialization of novel
therapies used in the areas of oncology, neurology, immunology and cardiology. The company operates in more than 90 countries
worldwide and principally operates in Canada, Australia, Japan and Europe. The company is headquartered in Massachusetts, U.S.
and employs 4,300 people approximately. The company recorded revenue of $3,062.9 million during the fiscal year ended December
2007, an increase of 18.2% over 2006. The operating profit of the company was $684.79 million during the fiscal year 2007, an
increase of 116.1% over 2006.
Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of
Biogen Idec Inc.. The report provides a comprehensive insight into the company, including business structure and operations,
executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's
views on the company.
Scope
-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational
factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
-The report contains critical company information ' business structure and operations, the company history, major products and
services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
-A quick 'one-stop-shop' to understand the company.
-Enhance business/sales activities by understanding customers' businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers ' with key data on their businesses and locations.
-Capitalize on competitors' weaknesses and target the market opportunities available to them.
-Compare your company's financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Biogen Idec Inc. - Financial and Strategic Analysis Review Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table of Content
Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
Overview 5
History 6
SWOT Analysis Overview 8
Overview 8
Biogen Idec Inc. - Strengths 8
Strong Performance 8
Strategic Agreements 8
Vast Geographical Presence 8
Biogen Idec Inc. - Weaknesses 8
High Dependence on Two Products 8
Lack of Manufacturing Facility 8
Biogen Idec Inc. - Opportunities 8
Growth in the Prevalence of Cancers 8
Pipeline Products 8
Increasing Demand in Niche Markets 9
Emerging Markets 9
Rising Healthcare Expenditure in the US 9
Medicare Part D 9
Biogen Idec Inc. - Threats 9
Decline in US Federal Funding for R&D 9
Highly Competitive Market 9
Tightening of the FDA's Regulatory Oversight 9
Changing Political Climate in the US 10
Emergence of Biogenerics / Biosimilars 10
Increased Pricing Control 10
Industry Consolidation 10
Key Competitors 11
Key Employees 11
Key Employee Biographies 12
Company Statement 15
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Financial Ratios 21
Capital Market Ratios 21
Biogen Idec Inc. - Financial and Strategic Analysis Review Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Annual Ratios 21
Interim Ratios 22
Ratio Charts 23
Appendix 24
Methodology 24
Ratio Definitions 24
About Global Markets Direct 27
Contact Us 27
Disclaimer 27List of Tables
Biogen Idec Inc., Key Facts 1
Biogen Idec Inc., Key Ratios 1
Biogen Idec Inc., Share Data 1
Biogen Idec Inc., Key Facts 4
Major Products and Services 5
Biogen Idec Inc., History 6
Biogen Idec Inc., Key Employees 11
Biogen Idec Inc., Key Employee Biographies 12
Biogen Idec Inc., Other Locations 19
Biogen Idec Inc., Subsidiaries 20
Biogen Idec Inc., Ratios based on current share price 21
Biogen Idec Inc., Annual Ratios 21
Biogen Idec Inc., Interim Ratios 22
Currency Codes 24
Capital Market Ratios 24
Equity Ratios 24
Profitability Ratios 25
Cost Ratios 25
Liquidity Ratios 25
Leverage Ratios 26
Efficiency Ratios 26List of Figures
Biogen Idec Inc., Performance Chart (2004 - 2008) 1
Biogen Idec Inc., Ratio Charts 23
Biogen Idec Inc. - Financial and Strategic Analysis Review Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Biogen Idec Inc. - Financial and Strategic Analysis Review
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Biogen Idec Inc. - Financial and Strategic Analysis Review Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Biogen Idec Inc. - Financial and Strategic Analysis Review Page 5/5